Skip to main content

Advertisement

SpringerLink
Log in

Evidence based medicine on the use of botulinum toxin for headache disorders

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Botulinum toxin blocks the release of acetylcholine from motor nerve terminals and other cholinergic synapses. In animal studies botulinum toxin also reduces the release of neuropeptides involved in pain perception. The implications of these observations are not clear. Based on the personal experiences of headache therapists, botulinum toxin injections have been studied in patients with primary headaches, namely tension-type headache (TTH), chronic migraine (CM) and chronic daily headache (CDH). So far, the results of randomized, double-blind, placebo controlled trials on botulinum toxin in a total of 1117 patients with CDH, 1495 patients with CM, and 533 patients with TTH have been published. Botulinum toxin and placebo injections have been equally effective in these studies. In some of the studies, the magnitude of this effect was similar to that of established oral pharmacotherapy. This finding may help to explain the enthusiasm that followed the first open-label use of botulinum toxin in patients with headache. However, research is continuing to determine the efficacy of botulinum toxin in certain subgroups of patients with CM or CDH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • SS Arnon R Schechter TV Inglesby DA Henderson JG Bartlett MS Ascher E Eitzen AD Fine J Hauer M Layton S Lillibridge MT Osterholm T O’Toole G Parker TM Perl PK Russell DL Swerdlow K Tonat (2001) ArticleTitleBotulinum toxin as a biological weapon: medical and public health management JAMA 285 1059–1070 Occurrence Handle11209178 Occurrence Handle10.1001/jama.285.8.1059 Occurrence Handle1:CAS:528:DC%2BD3MXhvFKgurw%3D

    Article  PubMed  CAS  Google Scholar 

  • SK Aurora M Gawel JL Brandes S Pokta AM Vandenburgh (2007) ArticleTitleBotulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study Headache 47 486–499 Occurrence Handle17445098 Occurrence Handle10.1111/j.1526-4610.2007.00853.x

    Article  PubMed  Google Scholar 

  • N Barrientos P Chana (2003) ArticleTitleBotulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study J Headache Pain 4 146–151 Occurrence Handle10.1007/s10194-003-0049-2 Occurrence Handle1:CAS:528:DC%2BD3sXpvVKqtb0%3D

    Article  CAS  Google Scholar 

  • W Blersch WJ Schulte-Mattler S Przywara A May H Bigalke K Wohlfarth (2002) ArticleTitleBotulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study J Neurol Sci 205 59–63 Occurrence Handle12409185 Occurrence Handle10.1016/S0022-510X(02)00313-1 Occurrence Handle1:CAS:528:DC%2BD38Xot1ais74%3D

    Article  PubMed  CAS  Google Scholar 

  • A Blumenfeld (2004) ArticleTitleBotulinum toxin type A for the treatment of headache: pro Headache 44 825–830 Occurrence Handle15330834 Occurrence Handle10.1111/j.1526-4610.2004.04154.x

    Article  PubMed  Google Scholar 

  • AM Blumenfeld W Binder SD Silberstein A Blitzer (2003) ArticleTitleProcedures for administering botulinum toxin type A for migraine and tension-type headache Headache 43 884–891 Occurrence Handle12940810 Occurrence Handle10.1046/j.1526-4610.2003.03167.x

    Article  PubMed  Google Scholar 

  • MF Brin S Fahn C Moskowitz A Friedman HM Shale PE Greene A Blitzer T List D Lange RE Lovelace et al. (1987) ArticleTitleLocalized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm Mov Disord 2 237–254 Occurrence Handle3504553 Occurrence Handle10.1002/mds.870020402 Occurrence Handle1:STN:280:DyaL1M%2FntVGktg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • DW Dodick A Mauskop AH Elkind R DeGryse MF Brin SD Silberstein (2005) ArticleTitleBotulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study Headache 45 315–324 Occurrence Handle15836567 Occurrence Handle10.1111/j.1526-4610.2005.05068.x

    Article  PubMed  Google Scholar 

  • M Dong F Yeh WH Tepp C Dean EA Johnson R Janz ER Chapman (2006) ArticleTitleSV2 is the protein receptor for botulinum neurotoxin A Science 312 592–596 Occurrence Handle16543415 Occurrence Handle10.1126/science.1123654 Occurrence Handle1:CAS:528:DC%2BD28XjvVGktbk%3D

    Article  PubMed  CAS  Google Scholar 

  • PL Durham R Cady R Cady (2004) ArticleTitleRegulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy Headache 44 35–42 Occurrence Handle14979881 Occurrence Handle10.1111/j.1526-4610.2004.04007.x

    Article  PubMed  Google Scholar 

  • Edlund W, Gronseth G, So Y, Franklin G (2004) Subcommittee for the Quality Standards Subcommittee and the Therapeutics and Technology Assessment Subcommittee. Clinical practice guideline process manual. Minneapolis: American Academy of Neurology, www.aan.com/globals/axon/assets/2535.pdf

  • L Edvinsson (2001) ArticleTitleSensory nerves in man and their role in primary headaches Cephalalgia 21 761–764 Occurrence Handle11595008 Occurrence Handle10.1046/j.1468-2982.2001.00245.x Occurrence Handle1:STN:280:DC%2BD3MrkvVKkuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • AH Elkind P O’Carroll A Blumenfeld R DeGryse R Dimitrova (2006) ArticleTitleA series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis J Pain 7 688–696 Occurrence Handle17018329 Occurrence Handle10.1016/j.jpain.2006.03.002 Occurrence Handle1:CAS:528:DC%2BD28XhtVantbvI

    Article  PubMed  CAS  Google Scholar 

  • S Evers J Vollmer-Haase S Schwaag A Rahmann IW Husstedt A Frese (2004) ArticleTitleBotulinum toxin A in the prophylactic treatment of migraine – a randomized, double-blind, placebo-controlled study Cephalalgia 24 838–843 Occurrence Handle15377314 Occurrence Handle10.1111/j.1468-2982.2004.00754.x Occurrence Handle1:STN:280:DC%2BD2cvmslSmsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • C Fernandes-de-las-Penas ML Cuadrado L Arendt-Nielsen DG Simons JA Pareja (2007) ArticleTitleMyofascial trigger points and sensitization: an updated pain model for tension-type headache Cephalalgia 27 383–393 Occurrence Handle10.1111/j.1468-2982.2007.01295.x

    Article  Google Scholar 

  • P Gazerani C Staahl AM Drewes L Arendt-Nielsen (2006) ArticleTitleThe effects of botulinum toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization Pain 122 315–325 Occurrence Handle16677761 Occurrence Handle10.1016/j.pain.2006.04.014 Occurrence Handle1:CAS:528:DC%2BD28XkvVCqsbY%3D

    Article  PubMed  CAS  Google Scholar 

  • MD Gill (1982) ArticleTitleBacterial toxins: a table of lethal amounts Microbiol Rev 46 86–94 Occurrence Handle6806598 Occurrence Handle1:CAS:528:DyaL38XhsFyrtr4%3D

    PubMed  CAS  Google Scholar 

  • PJ Goadsby L Edvinsson R Ekman (1990) ArticleTitleVasoactive peptide release in the extracerebral circulation of humans during migraine headache Ann Neurol 28 183–187 Occurrence Handle1699472 Occurrence Handle10.1002/ana.410280213 Occurrence Handle1:STN:280:DyaK3M%2FisVSktQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • M Hallett (1999) ArticleTitleOne man’s poison – clinical applications of botulinum toxin N Engl J Med 341 118–120 Occurrence Handle10395637 Occurrence Handle10.1056/NEJM199907083410209 Occurrence Handle1:STN:280:DyaK1MzgsFejsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • H Ishikawa Y Mitsui T Yoshitomi K Mashimo S Aoki K Mukuno K Shimizu (2000) ArticleTitlePresynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles Jpn J Ophthalmol 44 106–109 Occurrence Handle10715374 Occurrence Handle10.1016/S0021-5155(99)00197-5 Occurrence Handle1:CAS:528:DC%2BD3cXhslaktb8%3D

    Article  PubMed  CAS  Google Scholar 

  • HH Kramer C Angerer F Erbguth M Schmelz F Birklein (2003) ArticleTitleBotulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin J Neurol 250 188–193 Occurrence Handle12574949 Occurrence Handle10.1007/s00415-003-0971-x Occurrence Handle1:CAS:528:DC%2BD3sXivVGku70%3D

    Article  PubMed  CAS  Google Scholar 

  • WS Lee SM Moussaoui MA Moskowitz (1994) ArticleTitleBlockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva Br J Pharmacol 112 920–924 Occurrence Handle7921621 Occurrence Handle1:CAS:528:DyaK2cXkvF2ltbw%3D

    PubMed  CAS  Google Scholar 

  • S Mahrhold A Rummel H Bigalke B Davletov T Binz (2006) ArticleTitleThe synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves FEBS Lett 580 2011–2014 Occurrence Handle16545378 Occurrence Handle10.1016/j.febslet.2006.02.074 Occurrence Handle1:CAS:528:DC%2BD28XivV2qs7c%3D

    Article  PubMed  CAS  Google Scholar 

  • F Mancini R Zangaglia S Cristina MG Sommaruga E Martignoni G Nappi C Pacchetti (2003) ArticleTitleDouble-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism Mov Disord 18 685–688 Occurrence Handle12784273 Occurrence Handle10.1002/mds.10420

    Article  PubMed  Google Scholar 

  • NT Mathew BM Frishberg M Gawel R Dimitrova J Gibson C Turkel (2005) ArticleTitleBotulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial Headache 45 293–307 Occurrence Handle15836565 Occurrence Handle10.1111/j.1526-4610.2005.05066.x

    Article  PubMed  Google Scholar 

  • WG Ondo KD Vuong HS Derman (2004) ArticleTitleBotulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study Cephalalgia 24 60–65 Occurrence Handle14687015 Occurrence Handle10.1111/j.1468-2982.2004.00641.x Occurrence Handle1:STN:280:DC%2BD2c%2FhslSjtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • M Padberg SF de Bruijn RJ de Haan DL Tavy (2004) ArticleTitleTreatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial Cephalalgia 24 675–680 Occurrence Handle15265057 Occurrence Handle10.1111/j.1468-2982.2004.00738.x Occurrence Handle1:STN:280:DC%2BD2cvgsFChsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • LA Phebus KW Johnson PW Stengel KL Lobb JA Nixon PA Hipskind (1997) ArticleTitleThe non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs Life Sci 60 1553–1561 Occurrence Handle9126877 Occurrence Handle10.1016/S0024-3205(97)00121-5 Occurrence Handle1:CAS:528:DyaK2sXitl2nurY%3D

    Article  PubMed  CAS  Google Scholar 

  • DE Rapp KW Turk GT Bales SP Cook (2006) ArticleTitleBotulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder J Urol 175 1138–1142 Occurrence Handle16469640 Occurrence Handle10.1016/S0022-5347(05)00322-8 Occurrence Handle1:CAS:528:DC%2BD28XitFSit7w%3D

    Article  PubMed  CAS  Google Scholar 

  • M Relja AC Poole J Schoenen J Pascual X Lei C Thompson (2007) ArticleTitleA multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches Cephalalgia 27 492–503 Occurrence Handle17428299 Occurrence Handle10.1111/j.1468-2982.2007.01315.x Occurrence Handle1:STN:280:DC%2BD2szotFWruw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • JD Rollnik O Tanneberger M Schubert U Schneider R Dengler (2000) ArticleTitleTreatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study Headache 40 300–305 Occurrence Handle10759934 Occurrence Handle10.1046/j.1526-4610.2000.00044.x Occurrence Handle1:STN:280:DC%2BD3cvlvVentg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • RL Rosales H Bigalke D Dressler (2006) ArticleTitlePharmacology of botulinum toxin: differences between type A preparations Eur J Neurol 13 IssueIDSuppl 1 2–10 Occurrence Handle16417591 Occurrence Handle10.1111/j.1468-1331.2006.01438.x

    Article  PubMed  Google Scholar 

  • F Sakai S Ebihara M Akiyama M Horikawa (1995) ArticleTitlePericranial muscle hardness in tension-type headache. A non-invasive measurement method and its clinical application Brain 118 IssueID2 523–531 Occurrence Handle7735892 Occurrence Handle10.1093/brain/118.2.523

    Article  PubMed  Google Scholar 

  • G Schiavo M Matteoli C Montecucco (2000) ArticleTitleNeurotoxins affecting neuroexocytosis Physiol Rev 80 717–766 Occurrence Handle10747206 Occurrence Handle1:CAS:528:DC%2BD3cXisFShu7c%3D

    PubMed  CAS  Google Scholar 

  • WJ Schmitt E Slowey N Fravi S Weber JM Burgunder (2001) ArticleTitleEffect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial Headache 41 658–664 Occurrence Handle11554953 Occurrence Handle10.1046/j.1526-4610.2001.041007658.x Occurrence Handle1:STN:280:DC%2BD3MrgsFOisw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • P Schnider M Binder E Auff H Kittler T Berger K Wolff (1997) ArticleTitleDouble-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms Br J Dermatol 136 548–552 Occurrence Handle9155956 Occurrence Handle10.1046/j.1365-2133.1997.d01-1233.x Occurrence Handle1:CAS:528:DyaK2sXjtVaisbg%3D

    Article  PubMed  CAS  Google Scholar 

  • WJ Schulte-Mattler P Krack (2004) ArticleTitleTreatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study Pain 109 110–114 Occurrence Handle15082132 Occurrence Handle10.1016/j.pain.2004.01.016 Occurrence Handle1:CAS:528:DC%2BD2cXjtVCgurk%3D

    Article  PubMed  CAS  Google Scholar 

  • WJ Schulte-Mattler T Wieser S Zierz (1999) ArticleTitleTreatment of tension-type headache with botulinum toxin: a pilot study Eur J Med Res 4 183–186 Occurrence Handle10336407 Occurrence Handle1:CAS:528:DyaK1MXjslyqs78%3D

    PubMed  CAS  Google Scholar 

  • WJ Schulte-Mattler O Opatz W Blersch A May H Bigalke K Wohlfahrt (2007) ArticleTitleBotulinum toxin A does not alter capsaicin-induced pain perception in human skin J Neurol Sci 260 38–42 Occurrence Handle17481662 Occurrence Handle10.1016/j.jns.2007.03.023 Occurrence Handle1:CAS:528:DC%2BD2sXovFegsLg%3D

    Article  PubMed  CAS  Google Scholar 

  • S Silberstein N Mathew J Saper S Jenkins (2000) ArticleTitleBotulinum toxin type A as a migraine preventive treatment. For the BOTOX migraine clinical research group Headache 40 445–450 Occurrence Handle10849039 Occurrence Handle10.1046/j.1526-4610.2000.00066.x Occurrence Handle1:STN:280:DC%2BD3cvht1Ortg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • SD Silberstein SR Stark SM Lucas SN Christie RE Degryse CC Turkel (2005) ArticleTitleBotulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial Mayo Clin Proc 80 1126–1137 Occurrence Handle16178492 Occurrence Handle1:CAS:528:DC%2BD2MXhtVCjt77E Occurrence Handle10.4065/80.9.1126

    Article  PubMed  CAS  Google Scholar 

  • SD Silberstein H Gobel R Jensen AH Elkind R Degryse JM Walcott C Turkel (2006) ArticleTitleBotulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study Cephalalgia 26 790–800 Occurrence Handle16776693 Occurrence Handle10.1111/j.1468-2982.2006.01114.x Occurrence Handle1:STN:280:DC%2BD28zmtlaquw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • T Sycha D Samal B Chizh S Lehr B Gustorff P Schnider E Auff (2006) ArticleTitleA lack of antinociceptive or antiinflammatory effect of botulinum toxin a in an inflammatory human pain model Anesth Analg 102 509–516 Occurrence Handle16428552 Occurrence Handle10.1213/01.ane.0000194447.46763.73 Occurrence Handle1:CAS:528:DC%2BD28Xmslaitw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • JK Tsui A Eisen AJ Stoessl S Calne DB Calne (1986) ArticleTitleDouble-blind study of botulinum toxin in spasmodic torticollis Lancet 2 245–247 Occurrence Handle2874278 Occurrence Handle10.1016/S0140-6736(86)92070-2 Occurrence Handle1:STN:280:DyaL283otlOntQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • B Voller T Sycha B Gustorff L Schmetterer S Lehr HG Eichler E Auff P Schnider (2003) ArticleTitleA randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A Neurology 61 940–944 Occurrence Handle14557564 Occurrence Handle1:CAS:528:DC%2BD3sXns1ChsLk%3D

    PubMed  CAS  Google Scholar 

  • MJ Welch JR Purkiss KA Foster (2000) ArticleTitleSensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins Toxicon 38 245–258 Occurrence Handle10665805 Occurrence Handle10.1016/S0041-0101(99)00153-1 Occurrence Handle1:CAS:528:DyaK1MXns1Gqt7Y%3D

    Article  PubMed  CAS  Google Scholar 

  • K Wohlfarth H Goschel J Frevert R Dengler H Bigalke (1997) ArticleTitleBotulinum A toxins: units versus units Naunyn Schmiedebergs Arch Pharmacol 355 335–340 Occurrence Handle9089663 Occurrence Handle10.1007/PL00004951 Occurrence Handle1:CAS:528:DyaK2sXit1Sisbw%3D

    Article  PubMed  CAS  Google Scholar 

  • N Yokosawa K Suga K Kimura K Tsuzuki N Fujii K Oguma H Yokosawa (1994) ArticleTitleExogenous zinc ion is required for inhibitory activity of botulinum neurotoxin C1 against norepinephrine release and its endopeptidase activity toward substance P Biochem Mol Biol Int 32 455–463 Occurrence Handle7518276 Occurrence Handle1:CAS:528:DyaK2cXis1entbs%3D

    PubMed  CAS  Google Scholar 

  • JA Zwart G Bovim T Sand O Sjaastad (1994) ArticleTitleTension headache: botulinum toxin paralysis of temporal muscles Headache 34 458–462 Occurrence Handle7960729 Occurrence Handle10.1111/j.1526-4610.1994.hed3408458.x Occurrence Handle1:STN:280:DyaK2M%2FkvFCiuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Regensburg, Regensburg, Germany

    W. J. Schulte-Mattler & E. Leinisch

Authors
  1. W. J. Schulte-Mattler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Leinisch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. J. Schulte-Mattler.

Additional information

Correspondence: Wilhelm J. Schulte-Mattler, Department of Neurology, University of Regensburg, Universitätsstr. 84, 93053 Regensburg, Germany

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulte-Mattler, W., Leinisch, E. Evidence based medicine on the use of botulinum toxin for headache disorders. J Neural Transm 115, 647–651 (2008). https://doi.org/10.1007/s00702-007-0832-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-007-0832-3

Search

Navigation